Tenax Therapeutics (TENX) closed at $1.69 on November 11, 2026, unchanged from the previous close, on volume of 726,056 shares (30-day average 1,917,998).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 28, 2026 | Call Spread | 19-Jan-292 : 7.5 C | 320 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Newsfile (Thu, 12-Nov 12:47 PM ET)
PRNewswire (Thu, 12-Nov 10:11 AM ET)
Newsfile (Wed, 11-Nov 12:42 PM ET)
PRNewswire (Wed, 11-Nov 12:36 PM ET)
Newsfile (Tue, 10-Nov 10:37 PM ET)
PRNewswire (Tue, 10-Nov 2:10 PM ET)
Globe Newswire (Tue, 10-Nov 11:54 AM ET)
Business Wire (Tue, 10-Nov 11:04 AM ET)
Globe Newswire (Tue, 10-Nov 10:25 AM ET)
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Tenax Therapeutics trades on the NASDAQ stock market under the symbol TENX.
As of November 12, 2026, TENX stock price declined to $1.60 with 734,350 million shares trading.
TENX has a beta of 0.38, meaning it tends to be less sensitive to market movements. TENX has a correlation of 0.00 to the broad based SPY ETF.
TENX has a market cap of $72.86 million. This is considered a Micro Cap stock.
In the last 3 years, TENX traded as high as $61.20 and as low as $1.31.
The top ETF exchange traded funds that TENX belongs to (by Net Assets): VTI, IWM, IWN, VXF, VTWO.
TENX has underperformed the market in the last year with a price return of -77.3% while the SPY ETF gained +12.0%. However, in the short term, TENX had mixed performance relative to the market. It has outperformed in the last 3 months, returning -1.2% vs -1.5% return in SPY. But in the last 2 weeks, TENX shares have been beat by the market, returning -14.9% compared to an SPY return of -2.0%.
TENX support price is $1.59 and resistance is $1.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TENX shares will trade within this expected range on the day.
